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Background: Cardiac syndrome X includes a heterogenous group of patients with angina but
normal epicardial coronaries in angiography.
Objective: Our objective was to study the clinical characteristics of patients with cardiac
syndrome X.
Methods: Data of patients who underwent coronary angiography over a period of one year
was retrospectively analyzed. Those with normal or non-obstructive coronaries in angi-
ography with chest pain were included in this study.
Results: 1203 patients underwent coronary angiography during the study period. 105 (8.7%)
patients fulfilled the inclusion criteria. There were 52 (49.5%) males and 53 (50.5%) females
including 31 (29.5%) postmenopausal women. Many patients had atherosclerotic risk fac-
tors. Typical angina and atypical chest pain were reported by 63 (60%) and 42 (40%) pa-
tients, respectively. ECG was normal in 46 (43.8%) and abnormal in 59 (56.2%) patients. The
most common abnormal finding in ECG was ST-T changes seen in 49 (46.7%) patients.
Regional wall motion abnormality with mild left ventricular systolic dysfunction was seen
in 4 (3.8%) patients while 101 (96.2%) patients had normal ventricular function in echo-
cardiography. TMT was positive for inducible ischemia in 35 (33.3%) patients and incon-
clusive in 10 (9.5%) patients. Angiography showed normal epicardial coronaries in 85
(80.9%) patients.
Conclusions: Cardiac syndrome X constitutes a significant subset of patients undergoing
coronary angiography. It is essential to identify and treat them specifically for microvas-
cular angina. Many of them have atherosclerotic risk factors but their presentation is
different from those with obstructive coronaries.
Copyright © 2015, Cardiological Society of India. All rights reserved.t, Mudaliarpet, Puducherry 605004, India. Tel.: þ91 9443799346 (mobile).
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It is not infrequent to encounter patients with angina or
angina-like chest pain having normal or near-normal epicar-
dial coronaries in angiography.1,2 The term “Syndrome X”was
first introduced to define this diagnostic combination by Kemp
et al in 1973.3 Now this entity is known as “Cardiac Syndrome
X” (CSX) and it must be differentiated from “Metabolic Syn-
drome X” and Coronary Artery Disease (CAD). The former is
characterized by abdominal obesity, hypertension, reduced
high density lipoprotein cholesterol, hypertriglyceridemia and
insulin resistance,4 while the latter is characterized by
atherosclerotic obstructive coronaries.
The etiology of CSX is heterogenous.5,6 The proposed eti-
ologies are (i) endothelial dysfunction, (ii) microvascular
dysfunction or spasm and (iii) abnormal pain perception.7,8
Patients with CSX have abnormal endothelium-dependent
vasoreactivity and impaired vasodilator reserve of coro-
naries. Microvascular dysfunction or spasm is caused by
proinflammatory cytokines released from the dysfunctional
endothelium. Autonomic imbalance decreases pain threshold
and leads to hypersensitivity to changes in heart rate or
contractility.7 Truemyocardial ischemia occurs rarely in CSX.9
Despite the absence of angiographic abnormalities, many
patients with CSX have marked intimal thickening and
atheromatous plaque in coronaries on intra-vascular ultra-
sound imaging.10 Moreover, multislice computed tomography
scanning has shown that the incidence of coronary calcifica-
tion in CSX (53%) is significantly higher than normal controls
(20%) but lower than those with obstructive CAD (96%).11
According to prior studies, the prognosis of patients with
CSX is generally more favorable than those with obstructive
CAD.6,12,13 On the contrary, recent studies have reported
adverse cardiovascular outcomes in patients with non-
obstructive coronaries.14e16 We intended to understand
whether such adverse cardiovascular outcomes could be
secondary to any change in the clinical characteristics of pa-
tients with CSX in the current era. Hence we undertook this
study.Table 1 e Clinical profile.
Parameter n (%)
Age (mean ± SD) in years 52.9 ± 8.92. Aim
Our objective was to study the clinical characteristics of pa-
tients with cardiac syndrome X.Gender
Males 52 (49.5%)
Females 53 (50.5%)
Postmenopausal women 31 (29.5%)
Atherosclerotic risk factors
Hypertension 56 (53.3%)
Type 2 Diabetes mellitus 31 (29.5%)




Typical angina 63 (60%)
Atypical chest pain 42 (40%)
Note: n e number of patients; BMI e body mass index; SD e stan-
dard deviation.3. Materials and methods
This retrospective, observational study was carried out over a
period of one year in a tertiary care hospital. Coronary an-
giograms of patients who underwent coronary angiography,
for suspected ischemic heart disease, during the study periods
were reviewed. Patients with normal or non-obstructive cor-
onaries (less than 50% stenosis) in angiography with chest
pain were included in this study. The following were the
exclusion criteria for our study: coronary angiogram done
after acute myocardial infarction, post-revascularisation sta-
tus, structural heart disease, congenital heart disease andpreoperative indications. Clinical profile and details of inves-
tigation such as electrocardiography, echocardiography and
treadmill test were analyzed in all the patients included in this
study.
Statistical analysis was performed using SPSS software
(SPSS Inc. Released 2007. SPSS for Windows, Version 16.0.
Chicago: SPSS Inc) and two-tailed p value <0.05 was consid-
ered significant for all analyses. Categorical variables are
expressed as numbers and percentages displayed within pa-
rentheses while continuous variables with normal distribu-
tion are expressed as ‘Mean ± Standard deviation’.4. Results
A total of 1203 patients underwent coronary angiography
during the study period. Of these, 105 (8.7%) patients fulfilled
the inclusion criteria. The clinical profile of these subjects
included in the study is depicted in Table 1. There were 52
(49.5%)males and 53 (50.5%) females (p¼ 0.89, Chi Square test)
including 31 (29.5%) postmenopausal women with overall
mean age of 52.9 ± 8.9 years. There were 56 (53.3%) patients
with hypertension, 31 (29.5%) patients with type 2 diabetes, 17
(16.2%) patients with body mass index greater than 30 kg/m2,
32 (30.5%) patients with dyslipidemia and 19 (18.1%) patients
with smoking habit. Analysis of symptoms revealed typical
anginamore often than atypical chest pain present in 63 (60%)
and 42 (40%) patients, respectively (p ¼ 0.007, Fisher's exact
test).
Resting electrocardiogram was normal in 46 (43.8%) pa-
tients and abnormal in the remaining 59 (56.2%) patients.
Abnormal findings in ECG included ST-T changes in 49 (46.7%)
patients, Q wave in 5 (4.8%) patients and left bundle branch
block in 5 (4.8%) patients (Fig. 1). There was no statistically
significant difference between normal & abnormal findings in
ECG (p ¼ 0.09). Echocardiography revealed regional wall mo-
tion abnormality with mild left ventricular systolic dysfunc-
tion only in 4 (3.8%) patients while the majority of 101 (96.2%)
patients had normal study. Symptom-limited TMT performed
based on Bruce protocol was positive for inducible ischemia in
35 (33.3%) patients and inconclusive in 10 (9.5%) patients.
Fig. 1 e Electrocardiographic findings in patients with
cardiac syndrome X.
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included in the study showed normal epicardial coronaries in
85 (80.9%) patients, minor luminal irregularities in 11 (10.5%)
patients, ectasia of coronaries in 4 (3.8%) patients and slow
flow phenomenon in 6 (5.7%) patients (Table 2). One (0.9%) of
these patients had both coronary ectasia and slow flow
phenomenon.5. Discussion
In our study, the prevalence of CSX among those undergoing
coronary angiography was 8.7%. The prevalence of CSX re-
ported in earlier studies was 10e20%,11 20e30%,17 etc
depending on the inclusion criteria. There is no uniform
definition of ‘normal coronary arteries’ for diagnosing CSX18
in the literature. Though many studies included absolutely
normal coronaries, some studies included non-obstructive
lesions up to 50% stenoses.18e21 In our study, we included
patients with normal coronaries as well as non-obstructive
lesions. Around four-fifths of the patients had normal coro-
naries in our study.
There was no gender difference in our study and around
two-third of the women were postmenopausal. In contrast,
prior studies have shown that CSX is more frequently seen in
women1,11,17 and many of them are premenopausal.11,18 The
postmenopausal status of women and lack of gender differ-
ence with CSX seen in our study, could be one of theTable 2 e Angiographic profile.
Parameter n (%)
Normal epicardial coronaries 85 (80.9%)
Minor luminal irregularities 11 (10.5%)
Ectasia of coronaries 4 (3.8%)
Slow flow phenomenon 6 (5.7%)
Coronary ectasia and slow flow phenomenon 1 (0.9%)
Note: ne number of patients; LCXe left circumflex coronary artery;
RCA e right coronary artery.contributing factors for the change in the occurrence of other
clinical characteristics in patients with CSX. This in turn may
adversely affect the cardiovascular outcomes in CSX as it has
been recently reported.14e16 Another reason for the worsening
cardiovascular outcomes in patients with CSX would be the
inclusion of non-obstructive coronaries in the definition of
CSX. Lipid rich vulnerable plaques may be present in non-
obstructive coronaries22 and these are not detected during
routine coronary angiography. The presence of these high risk
vulnerable plaques may be predisposing factor for the wors-
ening cardiovascular outcomes in CSX.
Clinical presentation of chest pain in CSX has always been
elusive. In our study, typical angina was seen in 60% of the
patients with CSX while atypical chest pain was present in
40% of the patients only. As per the literature, chest pain in
CSX is more often atypical and it might resemble non-cardiac
chest pain.11 However, chest pain in CSX may be severe
enough to affect the quality of life of patients. Panic disorder
and exaggerated preoccupation about health may contribute
to chest pain in some patients with CSX.11
In our study, resting ECG showed predominantly ST-T
changes while ventricular systolic function in echocardiog-
raphy was normal inmajority of the patients with CSX. This is
similar to the description of CSX in the literature.11 Since,
stress echocardiographywas not done in our study, we are not
able to comment on the ventricular performance during
stress.23 In our study, no other stress imaging modality than
TMT was used, and it was positive for inducible ischemia in
33.3% of patients. In contrast, prior studies showed TMT
positivity in 20% of patients with CSX.11
Atherosclerotic risk factors were quite prevalent among
the patients with CSX in our study. Most of the studies on CSX
including our study are based on angiogram which is a lumi-
nogram. In the initial stages of atherosclerosis, outward
enlargement of wall of coronary artery occurs due to positive
remodeling and luminal narrowing occurs only in the later
stages.24 Hence the effect of atherosclerosis in patients with
CSX is generally underestimated. Previous studies have
demonstrated the link between insulin resistance and endo-
thelial dysfunction in CSX.25We did not study insulin levels in
our study.
5.1. Limitations of this study
In our study, intra-vascular ultrasound imaging and stress
echocardiography were not performed. Long-term prospec-
tive study is needed to understand the response to anti-
ischemic therapy, progression of symptoms and prognosis of
these patients with CSX. We are intending to address these
issues in our subsequent prospective study.6. Conclusions
In conclusion, cardiac syndrome X constitutes a significant
subset of patients undergoing coronary angiography. It is
essential to identify and treat them specifically for microvas-
cular angina. Many of these patients have atherosclerotic risk
factors but their clinical presentation is different from those
with obstructive coronaries. The postmenopausal status of
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obstructive coronaries could be the contributing factors for
the change in the clinical characteristics in the patients with
cardiac syndromeX and this in turnmay adversely affect their
cardiovascular outcomes.Conflicts of interest
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